MICHAEL CORSILLES: Open Payments
NPI 1023151081 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 8 payments from 6 companies in 2025. Trend: 2023 $212 · 2024 $427 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: ZENPEP, XYOSTED, XIFAXAN, HYMOVIS, APTIMA, QULIPTA.
Industry payments across WA — which companies pay providers there.
